Newborn Screening - Global Market Outlook (2017-2023)

October 2017 | 158 pages | ID: N30D30E7FC2EN
Stratistics Market Research Consulting

Abstracts

According to Stratistics MRC, the Global Newborn Screening Market is accounted from $599.77 million in 2016 to reach $1395.65 million by 2023 with a CAGR of 12.7%. Increasing chromosomal abnormalities in infants, growing awareness in urbanized nations and rising panel of newborn infections are some of the key factors fueling the market growth. However, lack of specialized infrastructure and socio- economic barriers in emerging countries are hindering the growth of the market. Government initiatives and screening of aging disorder provides ample opportunities for the market growth.

Newborn screening is the practice of testing all babies in their starting stage of life for certain disorders and situations that can delay their normal growth. This testing is necessary in each state and is normally performed before the baby leaves the hospital. The circumstances included in newborn screening can cause severe health problems starting in infancy or childhood. Early detection and treatment can help out to avoid intellectual and physical disabilities and life threatening illnesses.

By test type, Dried Blood Spot (DBS) testing is a simple method of collecting, shipping and storing blood samples. DBS sampling has been used for clinical and pre-clinical pharmacokinetic studies, taking advantage of smaller sampling needs and simplified sample collection and handling. DBS sampling has also been used for disease surveillance in emerging nations.

North America captured the largest market share owing to the increasing awareness and increasing prevalence of cardiovascular disorders. Asia-Pacific region is expected to grow at a faster rate during the forecast period due to rising fertility rates and newborn death rates in the region.

Some of the key players in Newborn Screening market include Perkinelmer, Inc., Natus Medical Incorporated, Agilent Technologies Inc., Covidien PLC, Trivitron Healthcare, AB Sciex LLC, Masimo Corporation, GE Healthcare, Waters Corporation, Bio-Rad Laboratories, Inc., Bio Tek Instruments, Inc., Cardinal Health, Inc., Medtronic Plc, Thermo Fisher Scientific, Inc., Zen Tech S.A. and Neogen Labs Pvt. Ltd.

Technologies Covered:

• Electrophoresis
• DNA-Based Assays
• Pulse Oximetry Screening Technology
• Tandem Mass Spectrometry (TMS)
• Immunoassays and Enzymatic Assays
• Hearing Screen Technology

Product Types Covered:

• Reagents and Assay Kits
• Instruments

Test Types Covered:

• Hearing Screen Test
• Dry Blood Spot Test
• Critical Congenital Heart Diseases (CCHD) Test

End-Users Covered:

• Ambulatory Care
• Hospitals
• Nursing Homes

Diseases Covered:

• Hearing Disability
• Blood Spot Disease
• Thyroid Disorder
• Sickle Cells Disease
• Maple Syrup Disease
• Critical Congenital Cardiac Disease

Regions Covered:

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• U.K
• Italy
• France
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• New Zealand
• South Korea
• Rest of Asia Pacific
• South America
• Argentina
• Brazil
• Chile
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• UAE
• Qatar
• South Africa
• Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Product Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL NEWBORN SCREENING MARKET, BY TECHNOLOGY

5.1 Introduction
5.2 Electrophoresis
5.3 DNA-Based Assays
5.4 Pulse Oximetry Screening Technology
5.5 Tandem Mass Spectrometry (TMS)
5.6 Immunoassays and Enzymatic Assays
5.7 Hearing Screen Technology

6 GLOBAL NEWBORN SCREENING MARKET, BY PRODUCT TYPE

6.1 Introduction
6.2 Reagents and Assay Kits
6.3 Instruments
  6.3.1 Newborn Hearing Screening Instruments
    6.3.1.1 Hearing Screening Accessories
    6.3.1.2 Hearing Screening Devices
  6.3.2 Newborn Disorder Screening Instruments
  6.3.3 Pulse Oximeters Instruments

7 GLOBAL NEWBORN SCREENING MARKET, BY TEST TYPE

7.1 Introduction
7.2 Hearing Screen Test
7.3 Dry Blood Spot Test
7.4 Critical Congenital Heart Diseases (CCHD) Test

8 GLOBAL NEWBORN SCREENING MARKET, BY END-USER

8.1 Introduction
8.2 Ambulatory Care
8.3 Hospitals
8.4 Nursing Homes

9 GLOBAL NEWBORN SCREENING MARKET, BY DISEASE

9.1 Introduction
9.2 Hearing Disability
9.3 Blood Spot Disease
9.4 Thyroid Disorder
9.5 Sickle Cells Disease
9.6 Maple Syrup Disease
9.7 Critical Congenital Cardiac Disease

10 GLOBAL NEWBORN SCREENING MARKET, BY GEOGRAPHY

10.1 Introduction
10.2 North America
  10.2.1 US
  10.2.2 Canada
  10.2.3 Mexico
10.3 Europe
  10.3.1 Germany
  10.3.2 U.K.
  10.3.3 Italy
  10.3.4 France
  10.3.5 Spain
  10.3.6 Rest of Europe
10.4 Asia Pacific
  10.4.1 Japan
  10.4.2 China
  10.4.3 India
  10.4.4 Australia
  10.4.5 New Zealand
  10.4.6 South Korea
  10.4.7 Rest of Asia Pacific
10.5 South America
  10.5.1 Argentina
  10.5.2 Brazil
  10.5.3 Chile
  10.5.4 Rest of South America
10.6 Middle East & Africa
  10.6.1 Saudi Arabia
  10.6.2 UAE
  10.6.3 Qatar
  10.6.4 South Africa
  10.6.5 Rest of Middle East & Africa

11 KEY DEVELOPMENTS

11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 COMPANY PROFILING

12.1 Perkinelmer, Inc.
12.2 Natus Medical Incorporated
12.3 Agilent Technologies Inc.
12.4 Covidien PLC
12.5 Trivitron Healthcare
12.6 AB Sciex LLC
12.7 Masimo Corporation
12.8 GE Healthcare
12.9 Waters Corporation
12.10 Bio-Rad Laboratories, Inc.
12.11 Bio Tek Instruments, Inc.
12.12 Cardinal Health, Inc.
12.13 Medtronic Plc
12.14 Thermo Fisher Scientific, Inc.
12.15 Zen Tech S.A.
12.16 Neogen Labs Pvt. Ltd.

List Of Tables

LIST OF TABLES

Table 1 Global Newborn Screening Market Outlook, By Region (2015-2023) ($MN)
Table 2 Global Newborn Screening Market Outlook, By Technology (2015-2023) ($MN)
Table 3 Global Newborn Screening Market Outlook, By Electrophoresis (2015-2023) ($MN)
Table 4 Global Newborn Screening Market Outlook, By DNA-Based Assays (2015-2023) ($MN)
Table 5 Global Newborn Screening Market Outlook, By Pulse Oximetry Screening Technology (2015-2023) ($MN)
Table 6 Global Newborn Screening Market Outlook, By Tandem Mass Spectrometry (TMS) (2015-2023) ($MN)
Table 7 Global Newborn Screening Market Outlook, By Immunoassays and Enzymatic Assays (2015-2023) ($MN)
Table 8 Global Newborn Screening Market Outlook, By Hearing Screen Technology (2015-2023) ($MN)
Table 9 Global Newborn Screening Market Outlook, By Product Type (2015-2023) ($MN)
Table 10 Global Newborn Screening Market Outlook, By Reagents and Assay Kits (2015-2023) ($MN)
Table 11 Global Newborn Screening Market Outlook, By Instruments (2015-2023) ($MN)
Table 12 Global Newborn Screening Market Outlook, By Newborn Hearing Screening Instruments (2015-2023) ($MN)
Table 13 Global Newborn Screening Market Outlook, By Newborn Disorder Screening Instruments (2015-2023) ($MN)
Table 14 Global Newborn Screening Market Outlook, By Pulse Oximeters Instruments (2015-2023) ($MN)
Table 15 Global Newborn Screening Market Outlook, By Test Type (2015-2023) ($MN)
Table 16 Global Newborn Screening Market Outlook, By Hearing Screen Test (2015-2023) ($MN)
Table 17 Global Newborn Screening Market Outlook, By Dry Blood Spot Test (2015-2023) ($MN)
Table 18 Global Newborn Screening Market Outlook, By Critical Congenital Heart Diseases (CCHD) Test (2015-2023) ($MN)
Table 19 Global Newborn Screening Market Outlook, By End-User (2015-2023) ($MN)
Table 20 Global Newborn Screening Market Outlook, By Ambulatory Care (2015-2023) ($MN)
Table 21 Global Newborn Screening Market Outlook, By Hospitals (2015-2023) ($MN)
Table 22 Global Newborn Screening Market Outlook, By Nursing Homes (2015-2023) ($MN)
Table 23 Global Newborn Screening Market Outlook, By Disease (2015-2023) ($MN)
Table 24 Global Newborn Screening Market Outlook, By Hearing Disability (2015-2023) ($MN)
Table 25 Global Newborn Screening Market Outlook, By Blood Spot Disease (2015-2023) ($MN)
Table 26 Global Newborn Screening Market Outlook, By Thyroid Disorder (2015-2023) ($MN)
Table 27 Global Newborn Screening Market Outlook, By Sickle Cells Disease (2015-2023) ($MN)
Table 28 Global Newborn Screening Market Outlook, By Maple Syrup Disease (2015-2023) ($MN)
Table 29 Global Newborn Screening Market Outlook, By Critical Congenital Cardiac Disease (2015-2023) ($MN)

Note: Tables for North America, Europe, APAC, South America and Middle East & Africa Regions are also represented in the same manner as above